{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:50:14Z","timestamp":1740808214658,"version":"3.38.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.7759\/cureus.79839","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:06:03Z","timestamp":1740769563000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Liver Injury Following Herbal Drink Consumption With Steatosis and Immune Activation: A Case Report"],"prefix":"10.7759","author":[{"given":"Helai","family":"Hussaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaniyi","family":"Fadeyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Boostany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T","family":"Flint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi H","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023, 79:516-37. 10.1016\/j.jhep.2023.03.017","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28323","article-title":"Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports","volume":"63","author":"Bj\u00f6rnsson ES","year":"2016","unstructured":"Bj\u00f6rnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports. Hepatology. 2016, 63:590-603. 10.1002\/hep.28323","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro VJ","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017, 65:363-73. 10.1002\/hep.28813","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-015-1471-3","article-title":"Hepatotoxicity of herbal and dietary supplements: an update","volume":"89","author":"Stickel F","year":"2015","unstructured":"Stickel F, Shouval D. Hepatotoxicity of herbal and dietary supplements: an update. Arch Toxicol. 2015, 89:851-65. 10.1007\/s00204-015-1471-3","journal-title":"Arch Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2008.05.009","article-title":"Acute and sub-chronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents","volume":"118","author":"Rhiouani H","year":"2008","unstructured":"Rhiouani H, El-Hilaly J, Israili ZH, Lyoussi B. Acute and sub-chronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents. J Ethnopharmacol. 2008, 118:378-86. 10.1016\/j.jep.2008.05.009","journal-title":"J Ethnopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04395.x","article-title":"Herbal hepatotoxicity: a critical review","volume":"75","author":"Teschke R","year":"2013","unstructured":"Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol. 2013, 75:630-6. 10.1111\/j.1365-2125.2012.04395.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study","volume":"46","author":"Licata A","year":"2014","unstructured":"Licata A, Maida M, Cabibi D, et al.. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study. Dig Liver Dis. 2014, 46:1116-20. 10.1016\/j.dld.2014.08.040","journal-title":"Dig Liver Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. Electronic address. easloffice@easloffice.eu; European Association for the Study of the Liver: EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019, 70:1222-61. 10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan G","year":"2015","unstructured":"Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015, 17:14. 10.3390\/ijms17010014","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00072","article-title":"Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps","volume":"6","author":"Teschke R","year":"2015","unstructured":"Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol. 2015, 6:72. 10.3389\/fphar.2015.00072","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040537","article-title":"Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics","volume":"17","author":"Garc\u00eda-Cort\u00e9s M","year":"2016","unstructured":"Garc\u00eda-Cort\u00e9s M, Robles-D\u00edaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci. 2016, 17:537. 10.3390\/ijms17040537","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2016.08.010","article-title":"Herbal and dietary supplement-induced liver injury","volume":"21","author":"de Boer YS","year":"2017","unstructured":"de Boer YS, Sherker AH. Herbal and dietary supplement-induced liver injury. Clin Liver Dis. 2017, 21:135-49. 10.1016\/j.cld.2016.08.010","journal-title":"Clin Liver Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung TM","year":"2013","unstructured":"Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol. 2013, 58:395-8. 10.1016\/j.jhep.2012.08.018","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman SL","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018, 24:908-22. 10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz N","year":"2005","unstructured":"Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005, 4:489-99. 10.1038\/nrd1750","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","article-title":"Idiosyncratic drug hepatotoxicity","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani N","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al.. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015, 148:1340-52.e7. 10.1053\/j.gastro.2015.03.006","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334221-acute-liver-injury-following-herbal-drink-consumption-with-steatosis-and-immune-activation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:06:05Z","timestamp":1740769565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334221-acute-liver-injury-following-herbal-drink-consumption-with-steatosis-and-immune-activation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.79839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}